Eagle Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Eagle Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $57.51 per share as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2023-03-23
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $57.51.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $58.51.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $59.20.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $59.29.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2022-12-31 | $57.51 10-K · filed 2023-03-23 |
| 2021-12-31 | $58.51 10-K · filed 2023-03-23 |
| 2020-12-31 | $59.20 10-K · filed 2023-03-23 |
| 2019-12-31 | $59.29 10-K · filed 2022-03-08 |
| 2018-12-31 | $62.78 10-K · filed 2021-03-05 |
| 2017-12-31 | $57.13 10-K · filed 2020-03-02 |
| 2016-12-31 | $44.53 10-K · filed 2019-02-28 |
| 2015-12-31 | $25.16 10-K · filed 2018-02-26 |
| 2014-12-31 | $8.29 10-K · filed 2017-03-15 |
| 2014-09-30 | $8.16 10-K · filed 2017-03-15 |
| 2013-09-30 | $5.58 10-K · filed 2016-02-29 |
| 2012-09-30 | $6.22 10-K · filed 2014-12-22 |
| 2011-09-30 | $5.32 10-K · filed 2014-12-22 |